You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 89 No. 2, August 1964 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Citing articles on Web of Science (18)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Treatment of Experimental Tumors

Utilization of Radioactive Microspheres

ROBERT J. BLANCHARD, MD; IVAN GROTENHUIS, MS; JAMES W. LaFAVE, MD; CHARLES W. FRYE, MD; JOHN F. PERRY, JR., MD

AMA Arch Surg. 1964;89(2):406-410.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Experimental and clinical studies evaluating the usefulness of radioactive microspheres in treatment of tumors have been in progress since 1960. Ceramic or plastic in composition, these spheres have been found to have many uses in industry. As carriers of radioactive isotopes they have several features favorable to medical application.1 Almost any cation can be incorporated as the microspheres act like exchange resins. The bond is then made permanent by firing in a kiln. Very high specific activities can be achieved (up to 10 curies Y90/gm). The spheres can be accurately segregated into groups of uniform size varying from 15µ to 500µ. Finally, the spheres themselves are biologically inert and resist leaching even in strong acids and/or alkalis.

In experiments previously reported by LaFave and associates2 it was shown that the administration of Y90 microspheres into the rabbit mesenteric vein along with VX2 carcinoma cells prevents . . . [Full Text PDF of this Article]


Author Affiliations

ST. PAUL

From the departments of surgery and radiation therapy, Ancker Hospital, and the University of Minnesota Medical School, Minneapolis.


Footnotes

Read before the 21st Annual Meeting of the Central Surgical Association, Rochester, Minn, Feb 27-29, 1964.

Supported by research grant No. AT(11-1)-1305 Atomic Energy Commission, and a grant from the United Fund of St. Paul.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1964 American Medical Association. All Rights Reserved.